Followers | 4 |
Posts | 190 |
Boards Moderated | 0 |
Alias Born | 02/10/2023 |
Tuesday, March 14, 2023 1:37:56 PM
Is there a reason for the drop of down another 9% today. There is no news and maybe that is the issue. Until they get close to a deal the share price may struggle. I have the shares I wanted and I guess that will need to do. I will now just sit back and wait for something positive to happen.
The conference is likely a non event. The parties are forced to attend but there is nothing to indicate a resolution will be reached. I believe the judge meets with the parties ahead of the conference. The best outcome is if the facts have been reviewed by the judge and he can tell META or AMZN or the others that based on the facts it appears they will lose when they go to trial. That it would be in their best interest to settle prior to the trial.
If META goes into the conference knowing that the facts are leaning in VPLM's favor there would be a high likelihood that a settlement could be reached. But as many already know it is unlikely a settlement is reached by AMZN until the trial is close. My guess is June at the earliest. META seems to be at an earlier stage. I don't understand the reason for a settlement conference now. Maybe META and the judge feel strongly that their case is weak and META wants to have the conference. That would be the best case scenario. If META wants to settle and the 2 parties are forced to negotiate in a room for the entire day there could be some real progress made.
As someone said earlier if META or one of the others bought the company and the patents that go with it they could get an advantage on their competition. Let's hope someone at one of these companies determines the patents are defendable and decides they want to buy the patents soon. I have no expectations of $5 or $10 a share. I would be fine with $.05 to $2 a share. Someone buys at that price and I would be thrilled.
A purchase tomorrow would be fine with me.
Recent VPLM News
- ILUS International Inc (ILUS) Sees 557% Q1 Revenue Increase, Begins National Exchange Uplist Procedure for Subsidiaries and Company • InvestorsHub NewsWire • 06/05/2023 12:15:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM